Upstream assists Children's National Medical Center in Robotic Surgery venture
Upstream Partners helped negotiate a license and structure a transaction that provided Omniboros, Inc., a robotic surgery company spun out of Children's National Health System, with a license to a large patent portfolio and additional know-how.. Omniboros raised $1.5 million in funding from Great Point Ventures, a Silicon Valley-based venture capital firm.
The technology, known as the Smart Tissue Autonomous Robot, or STAR, has demonstrated the ability to conduct autonomous soft tissue surgery with a robotic device. The device has demonstrated the ability to suture live pigs and inanimate pig tissue with more precision than a human hand. Omniboros, based in Washington, DC., will continue in vivo testing throughout 2017 and 2018.
Click here to view the article.